BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2543331)

  • 1. [Effect of human epidermal factor (hEGF) on antitumor activity of 5-fluorouracil (5-FU) in human gastric cancer cell lines].
    Saito D; Yoshida S; Okazaki N; Ohkura H
    Gan To Kagaku Ryoho; 1989 May; 16(5):2117-20. PubMed ID: 2543331
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental chemotherapy of human gastric cancer cell lines in vitro and in nude mice].
    Pan XY; Li FQ; Yu RJ; Xie GF; Wang H; Zhao LY; Zhang Q
    Zhonghua Zhong Liu Za Zhi; 1988 Jan; 10(1):15-8. PubMed ID: 2843330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemosensitivity of MGc 80-3 human gastric adenocarcinoma cells and its clinical significance].
    Li XT
    Zhonghua Zhong Liu Za Zhi; 1989 Sep; 11(5):332-4. PubMed ID: 2559835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of medroxyprogesterone acetate on the anticellular activity of 5-fluorouracil against human breast and stomach cancer cells].
    Ishida H; Okabe M; Gomi K; Horiuchi R
    Gan To Kagaku Ryoho; 1993 Apr; 20(5):625-30. PubMed ID: 8470920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of various strategies to enhance the cytotoxic activity of 5-fluorouracil/leucovorin in human colorectal cancer cell lines.
    Scheithauer W; Temsch EM
    Anticancer Res; 1989; 9(6):1793-8. PubMed ID: 2627128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental study of biochemical modulation of 5-fluorouracil with l-leucovorin against human esophageal cancer].
    Terashima M; Ikeda K; Kawamura H; Maesawa C; Takiyama I; Yoshinari H; Koeda K; Sato N; Ishida K; Saito K
    Gan To Kagaku Ryoho; 1992 Oct; 19(12):1999-2004. PubMed ID: 1417007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of combined use of chemotherapeutic agents and hematopor--phyrin derivative (HPD) on human gastric cancer cell line in vitro].
    Niu MY
    Zhonghua Zhong Liu Za Zhi; 1992 Jan; 14(1):70-2. PubMed ID: 1327693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined effect of 5-fluorouracil and carboplatin against human gastric cancer cell lines in vitro and in vivo.
    Saikawa Y; Kubota T; Kuo TH; Tanino H; Kase S; Furukawa T; Watanabe M; Ishibiki K; Kitajima M; Hoffman RM
    Anticancer Res; 1994; 14(2A):461-4. PubMed ID: 8017848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen up-regulates epidermal growth factor receptor expression and binding affinity in PC3 cell lines expressing the human androgen receptor.
    Brass AL; Barnard J; Patai BL; Salvi D; Rukstalis DB
    Cancer Res; 1995 Jul; 55(14):3197-203. PubMed ID: 7606741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation of 5-fluorouracil cytotoxicity by epidermal growth factor in a newly established human signet-ring cell carcinoma of the stomach in culture.
    Aizawa K; Muto I; Suzuki S; Tanaka N; Yabusaki H; Tanaka S; Katayanagi N; Suzuki T; Tanaka O; Muto T
    Surg Today; 1994; 24(5):420-8. PubMed ID: 8054813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiproliferative effect of tyrosine kinase inhibitors in epidermal growth factor-stimulated growth of human gastric cancer cells.
    Piontek M; Hengels KJ; Porschen R; Strohmeyer G
    Anticancer Res; 1993; 13(6A):2119-23. PubMed ID: 8297123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor release by human tumor cell lines and their interactions with other growth factors.
    Rueda F; Piñol G; Gonzalez-Garrigues M; Marti F; Fabra A
    Anticancer Res; 1989; 9(4):1245-8. PubMed ID: 2683995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human epidermal growth factor in gastric carcinoma as a biologic marker of high malignancy.
    Tahara E; Sumiyoshi H; Hata J; Yasui W; Taniyama K; Hayashi T; Nagae S; Sakamoto S
    Jpn J Cancer Res; 1986 Feb; 77(2):145-52. PubMed ID: 2420773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomerase assay as a possible predictor of the response to anticancer chemotherapy.
    Terashima M; Takiyama I; Uesugi N; Sasaki N; Takagane A; Hayakawa Y; Abe K; Araya M; Nishizuka S; Shimooki O; Nakaya T; Irinoda T; Yonezawa H; Oyama K; Saito K
    Anticancer Res; 2000; 20(1A):293-7. PubMed ID: 10769670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydropyrimidine dehydrogenase: a tumoral target for fluorouracil modulation.
    Fischel JL; Etienne MC; Spector T; Formento P; Renée N; Milano G
    Clin Cancer Res; 1995 Sep; 1(9):991-6. PubMed ID: 9816071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combination of a biscoclaurine alkaloid, cepharanthine, and anticancer agents: effects and mechanism in human gastric and pancreatic carcinoma cell lines].
    Nishiyama M; Aogi K; Saeki S; Hirabayashi N; Toge T
    Gan To Kagaku Ryoho; 1991 Nov; 18(14):2429-33. PubMed ID: 1952962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
    Kim R; Tanabe K; Inoue H; Toge T
    Int J Oncol; 2002 Mar; 20(3):549-55. PubMed ID: 11836567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of phorbol esters on cell growth and epidermal growth factor receptor modulation in a human gastric carcinoma cell line TMK-1.
    Ochiai A; Yasui W; Kameda T; Takanashi A; Takekura N; Tahara E
    Hiroshima J Med Sci; 1989 Dec; 38(4):191-5. PubMed ID: 2637248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined effect of 5-fluorouracil and recombinant tumor necrosis factor against human gastric carcinoma cell lines.
    Li Y; Ito S; Cheng W; Ishii Y
    Anticancer Res; 1996; 16(4A):1771-4. PubMed ID: 8712699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on the effects of human chorionic gonadotropin on the growth of human gastric adenocarcinoma cells].
    Zhang Q; Liao Y; Li R; Chen M
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Oct; 34(4):678-9. PubMed ID: 14619579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.